Was bedeutet "Clear"?
Das Tier trägt die Mutation nicht. Es wird nicht zur Krankheit kommen und werde es nicht weitergeben.
Hund Angeborenes myasthenes Syndrom beim Labrador Retriever (CMS-LR)
Discover the importance of DNA testing for Congenital Myasthenic Syndrome (CMS) in Labrador Retrievers. This genetic disorder affects muscle function and can lead to severe health issues in your furry friend. By conducting a CMS DNA test, you can identify carriers and affected dogs, ensuring responsible breeding practices. Early detection allows for better management of symptoms and enhances your Labrador's quality of life. Protect your beloved pet from potential health risks associated with CMS. Invest in a DNA test today and contribute to the health and longevity of Labrador Retrievers. Stay informed and make the best decisions for your dog's well-being!
Abkürzung : CMS-LR
Analysierte Mutation: LOC608697 c.1010T>C
Nachlass : Autosomal-rezessiv
Akronym
CMS-LR
Beobachtete Häufigkeit
Klinischer Schweregrad
Klinische Klassifizierung
Neuromuskuläre Erkrankungen
Analysierte Mutation
LOC608697 c.1010T>C
p.(I337T)
p.(I337T)
Art der Vererbung
Autosomal-rezessiv
Testzusammenfassung:
Congenital Myasthenic Syndrome (CMS) is a hereditary condition affecting Labrador Retrievers, characterized by muscle weakness and fatigue. A DNA test can identify carriers of the gene responsible for this disorder, allowing responsible breeding practices to minimize the risk of passing it on. Early diagnosis through genetic testing can enhance the management of affected dogs, improving their quality of life. Owners are encouraged to consult veterinarians for testing options and implications. By understanding CMS, we can promote healthier generations of Labradors.
Erhältlich in der Packung: Basic
Dieser DNA-Test ist ab unserem Paket enthalten Basic — und ist auch Teil der Packungen Basic, Standard, Advanced, Complete.
DNA-Testpakete anzeigen →Wählen Sie das Paket, das am besten zu Ihrer Zucht- oder Gesundheitsstrategie Ihrer Tiere passt.
Understanding Congenital Myasthenic Syndrome (CMS) in Labrador Retrievers
Congenital Myasthenic Syndrome (CMS) is a genetic disorder that affects the neuromuscular transmission in dogs, particularly noted in Labrador Retrievers. This condition arises due to mutations in genes responsible for the function and maintenance of neuromuscular junctions, leading to muscle weakness and fatigue. It is essential for dog owners and breeders to be aware of this condition, as it can significantly impact the quality of life of affected animals.
Symptoms of Congenital Myasthenic Syndrome
The symptoms of CMS can vary, but they typically include muscle weakness, especially after exercise, difficulty swallowing, and a tendency to collapse after exertion. Affected dogs may also exhibit signs of respiratory distress due to weakened muscles involved in breathing. These symptoms often manifest early in life, making it crucial for owners to recognize them promptly to seek veterinary advice.
Diagnosis of Congenital Myasthenic Syndrome
Diagnosing CMS involves a combination of clinical examination and genetic testing. Veterinarians may observe the characteristic symptoms and perform a thorough neurological examination. However, definitive diagnosis is usually confirmed through DNA tests that identify specific genetic mutations associated with the syndrome. This genetic testing plays a vital role in assessing the risk of the condition in breeding programs.
Management- und Behandlungsoptionen
Currently, there is no definitive cure for CMS; however, management strategies can help improve the quality of life for affected dogs. Treatment often includes the use of medications that enhance neuromuscular transmission, such as anticholinesterase agents. Supportive care, including dietary modifications and physical therapy, may also be beneficial in managing symptoms and improving muscle strength.
The Role of Genetic Testing in Breeding
Genetic testing for CMS is an essential tool for responsible breeding practices. By identifying carriers of the genetic mutations associated with CMS, breeders can make informed decisions to reduce the incidence of this condition in future generations. This proactive approach not only helps in maintaining the health of Labrador Retrievers but also contributes to the overall welfare of the breed.
Fazit
Congenital Myasthenic Syndrome poses significant challenges for Labrador Retrievers and their owners. Understanding the symptoms, diagnosis, and management of this condition is critical for ensuring affected dogs receive the appropriate care. Additionally, genetic testing plays a pivotal role in breeding practices, enabling breeders to make informed decisions that can help mitigate the risk of CMS within the breed. Awareness and education are key to improving outcomes for dogs affected by this syndrome.
Für die Prüfung anerkannte Rasse: Angeborenes myasthenes Syndrom beim Labrador Retriever (CMS-LR)
- Australian Cobberdog
- Labradoodle
- Labrador Retriever
- UK Breed Council Labrador Retriever
🧬 Interpretation of genotypes CMS-LR
Genotyp
Status
🟡 N/N
Nicht-Träger - Kein Risiko
🟡 N/CMS-LR
Carrier - Kein Risiko
❌ CMS-LR/CMS-LR
Betroffen - Gefährdet
FAQ: das Verständnis der Interpretation
Ist ein „Carrier“ ernsthaft?
Nein. Das Tier ist im Allgemeinen gesund, kann die Mutation aber auf sein Tier übertragen Nachkommen.
Was passiert, wenn ein Tier "betroffen" ist?
Es trägt zwei mutierte Kopien. Klinische Symptome sind abhängig davon zu erwarten die Krankheit. Es sollte nicht gezüchtet werden.
Warum gibt es Unterschiede zwischen Männern und Frauen?
Einige Krankheiten sind geschlechtsgebunden, daher variiert ihre Ausprägung je nach Erkrankung Geschlecht des Tieres.
Nachkommen vorhersagen
N/N (nicht-trager)
N/CMS-LR (Träger)
CMS-LR/CMS-LR (Betroffen)
Häufig gestellte Fragen zum DNA-Test
Was erkennt dieser DNA-Test?
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome In Labrador Retriever (CMS) in order to identify clear, carrier, or at-risk animals.
Warum ein Zuchttier testen?
DNA-Tests helfen Züchtern, sicherere Paarungen zu planen und das Risiko einer Übertragung der Mutation auf die Nachkommen zu verringern.
Was ist der Vererbungsmodus dieses Tests?
Der für diesen Test gemeldete Vererbungsmodus ist autosomal rezessiv.
Welche Mutation wird in diesem Test analysiert?
This test analyses the mutation LOC608697 c.1010T>C.
Ist ein Trägertier zwangsläufig betroffen?
Nicht unbedingt. Die Interpretation hängt vom Vererbungsmuster und dem resultierenden Genotyp ab.
Referenzen
Rinz Caitlin J, Levine Jonathan, Minor Katie M, Humphries Hammon D, Lara Renee, StarrMoss Alison N, Guo Ling T, Williams D Colette, Shelton G Diane, Clark Leigh Anne. A COLQ missense mutation in Labrador Retrievers having congenital myasthenic syndrome. PLoS One. 2014 Aug 28;9(8):e106425. doi: 10.1371/journal.pone.0106425. eCollection 2014.